Investment Information

With transparent disclosure of information and communication with markets,
we will grow along with shareholders.

Disclosures & Reports

Public Disclosures

NO Title Date Submission Obligator
10 Reporting reasons for holding general shareholders' meeting on the most concentrated date 2019/03/07 HANALL BIOPHARMA CO.,LTD
9 Decision on Calling Shareholders' Meeting 2019/03/06 HANALL BIOPHARMA CO.,LTD
8 Submission of Audit Report 2019/03/06 HANALL BIOPHARMA CO.,LTD
7 Organization of Investor Relations Event 2019/02/21 HANALL BIOPHARMA CO.,LTD
6 Implementation and Operation of Compliance Program of the Fair Trade Commission 2019/02/08 HANALL BIOPHARMA CO.,LTD
5 30% or More Changes in Sales or Profits/Losses (15% or More in the case of Large-scale Corporations) 2019/01/14 HANALL BIOPHARMA CO.,LTD
4 Closure of Stock Transfer (Shareholder's Registry) 2018/12/14 HANALL BIOPHARMA CO.,LTD
3 Organization of Investor Relations Event 2018/11/27 HANALL BIOPHARMA CO.,LTD
2 Organization of Investor Relations Event 2018/11/26 HANALL BIOPHARMA CO.,LTD
1 Organization of Investor Relations Event 2018/10/11 HANALL BIOPHARMA CO.,LTD

Electronic Announcement

공시정보 전자공고 목록
NO Title Date Related Data
1 2017 Statement of financial position 2018-03-30

Management Regulation on Public Announcement

공시정보 전자공고 목록
NO Title Date Related Data
1 Management Regulation on Public Announcement 2009-08-31